Antibiotic therapy with metronidazole reduces endometriosis disease progression in mice: a potential role for gut microbiota
- PMID: 31037294
- PMCID: PMC6554192
- DOI: 10.1093/humrep/dez041
Antibiotic therapy with metronidazole reduces endometriosis disease progression in mice: a potential role for gut microbiota
Abstract
Study question: Does altering gut microbiota with antibiotic treatment have any impact on endometriosis progression?
Summary answer: Antibiotic therapy reduces endometriosis progression in mice, possibly by reducing specific gut bacteria.
What is known already: Endometriosis, a chronic condition causing abdominal pain and infertility, afflicts up to 10% of women between the ages of 25 and 40, ~5 million women in the USA. Current treatment strategies, including hormone therapy and surgery, have significant side effects and do not prevent recurrences. We have little understanding of why some women develop endometriosis and others do not.
Study design, size, duration: Mice were treated with broad-spectrum antibiotics or metronidazole, subjected to surgically-induced endometriosis and assayed after 21 days.
Participants/materials, setting, methods: The volumes and weights of endometriotic lesions and histological signatures were analysed. Proliferation and inflammation in lesions were assessed by counting cells that were positive for the proliferation marker Ki-67 and the macrophage marker Iba1, respectively. Differences in faecal bacterial composition were assessed in mice with and without endometriosis, and faecal microbiota transfer studies were performed.
Main results and the role of chance: In mice treated with broad-spectrum antibiotics (vancomycin, neomycin, metronidazole and ampicillin), endometriotic lesions were significantly smaller (~ 5-fold; P < 0.01) with fewer proliferating cells (P < 0.001) than those in mice treated with vehicle. Additionally, inflammatory responses, as measured by the macrophage marker Iba1 in lesions and IL-1β, TNF-α, IL-6 and TGF-β1 in peritoneal fluid, were significantly reduced in mice treated with broad-spectrum antibiotics (P < 0.05). In mice treated with metronidazole only, but not in those treated with neomycin, ectopic lesions were significantly (P < 0.001) smaller in volume than those from vehicle-treated mice. Finally, oral gavage of faeces from mice with endometriosis restored the endometriotic lesion growth and inflammation (P < 0.05 and P < 0.01, respectively) in metronidazole-treated mice.
Large-scale data: N/A.
Limitations, reasons for caution: These findings are from a mouse model of surgically-induced endometriosis. Further studies are needed to determine the mechanism by which gut bacteria promote inflammation, identify bacterial genera or species that promote disease progression and assess the translatability of these findings to humans.
Wider implications of the findings: Our findings suggest that gut bacteria promote endometriosis progression in mice. This finding if translated to humans, could aid in the development of improved diagnostic tools and personalised treatment strategies.
Study funding and competing interest(s): This work was funded, in part, by: a National Institutes of Health (NIH)/ National Institute of Child Health and Human Development (NICHD) grant (R00HD080742) to RK; Washington University School of Medicine start-up funds to RK; an Endometriosis Foundation of America Research Award to R.K.; and an NIH/NICHD grant (R01HD091218) to IUM. The authors report no conflict of interest.
Keywords: endometriosis; gut bacteria; inflammation; metronidazole; microbiome.
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Figures
Similar articles
-
Endometriosis induces gut microbiota alterations in mice.Hum Reprod. 2018 Apr 1;33(4):607-616. doi: 10.1093/humrep/dex372. Hum Reprod. 2018. PMID: 29462324
-
Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis.Hum Reprod. 2013 May;28(5):1339-47. doi: 10.1093/humrep/det031. Epub 2013 Feb 20. Hum Reprod. 2013. PMID: 23427233
-
Hypothetical roadmap towards endometriosis: prenatal endocrine-disrupting chemical pollutant exposure, anogenital distance, gut-genital microbiota and subclinical infections.Hum Reprod Update. 2020 Feb 28;26(2):214-246. doi: 10.1093/humupd/dmz044. Hum Reprod Update. 2020. PMID: 32108227 Review.
-
The cannabinoid receptor CB1 contributes to the development of ectopic lesions in a mouse model of endometriosis.Hum Reprod. 2017 Jan;32(1):175-184. doi: 10.1093/humrep/dew281. Epub 2016 Nov 7. Hum Reprod. 2017. PMID: 27821707
-
The role of gut and genital microbiota and the estrobolome in endometriosis, infertility and chronic pelvic pain.Hum Reprod Update. 2021 Dec 21;28(1):92-131. doi: 10.1093/humupd/dmab035. Hum Reprod Update. 2021. PMID: 34718567 Review.
Cited by
-
Mapping uterine calcium dynamics during the ovulatory cycle in live mice.PNAS Nexus. 2024 Oct 4;3(10):pgae446. doi: 10.1093/pnasnexus/pgae446. eCollection 2024 Oct. PNAS Nexus. 2024. PMID: 39430221 Free PMC article.
-
The gut microbiota: emerging biomarkers and potential treatments for infertility-related diseases.Front Cell Infect Microbiol. 2024 Sep 26;14:1450310. doi: 10.3389/fcimb.2024.1450310. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39391885 Free PMC article. Review.
-
Gut and oral microbiota in gynecological cancers: interaction, mechanism, and therapeutic value.NPJ Biofilms Microbiomes. 2024 Oct 10;10(1):104. doi: 10.1038/s41522-024-00577-7. NPJ Biofilms Microbiomes. 2024. PMID: 39389989 Free PMC article. Review.
-
The gut microbiome and chronic pain.Nature. 2024 Sep;633(8031):S34-S36. doi: 10.1038/d41586-024-03006-z. Nature. 2024. PMID: 39322726 No abstract available.
-
Relationship between triglyceride-glucose index and endometriosis: a cross-sectional analysis.BMC Womens Health. 2024 Aug 8;24(1):447. doi: 10.1186/s12905-024-03287-6. BMC Womens Health. 2024. PMID: 39118074 Free PMC article.
References
-
- Bacci M, Capobianco A, Monno A, Cottone L, Di Puppo F, Camisa B, Mariani M, Brignole C, Ponzoni M, Ferrari S et al. . Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol 2009;175:547–556. - PMC - PubMed
-
- Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 2011;9:88–96. - PubMed
-
- Brook I. Pathogenicity of the Bacteroides fragilis group. Ann Clin Lab Sci 1989;19:360–376. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials